×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
#0432 The first assistant puts on a virtual reality headset (Meta Quest) to assist with da Vinci robotic surgery
04-24
#0087 Holographic Imaging-assisted Robotic Partial Adrenalectomy for Adrenal Tumor: Technique and Outcomes from a Single Center
04-24
#1372 Improved CSPCa Detection Rate by MRI-TRUS Fusion Biopsy Compared to Conventional Biopsy: A Large Single-Center Experience
04-23
#1338 Transperineal Prostate Biopsy Using Freehand Technique Under Local Anaesthetic: A Systematic Review and Meta-analysis
04-23
#1322 Deintensification of androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer: an exploratory study of survival outcomes and predictive factors
04-23
#1290 Targeted Versus Targeted Plus Random Transperineal MR/US Prostate Biopsy in patients with a single lesion on MRI: Is There Added Value?
04-23
#1278 PREDICTIVE FACTORS OF PATHOLOGICAL UPGRADING IN INDIAN PATIENTS WITH GLEASON SCORE 3+4 PROSTATE CANCER: WHEN TO OFFER ACTIVE SURVEILLANCE?
04-23
#1233 Comparison of Ga68 PSMA-PET/MRI Fusion Based Cognitive-Targeted versus MRI-TRUS Fusion Biopsy for the Diagnosis of Prostate Cancer- A Pilot Study
04-23
#1186 Analysis of Time to Prostate-specific antigen (PSA) Nadir After Radical Prostatectomy In Taiwan
04-23
#1168 Prostate Cancer: A Novel MRI-Based Predictive Model Co-Registered with Whole-Mount Pathology
04-23
#1166 Diagnostic efficacy of 68Ga-PSMA-PET/CT scan as a single staging modality in prostate cancer: Evidence from a tertiary healthcare centre
04-23
#1151 Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer Patients: A Prospective Study
04-23
#1117 Gleason 6 cancer - time for a rebrand?
04-23
#1114 Prostate Cancer Management Across Asia and Oceania: Insights from a Multi-Country UAA Survey
04-23
#0851 SPP1+ Macrophage/FAP+ Fibroblast Crosstalk Predicts Disease Progression and Immunosuppressive Niche in Prostate Cancer
04-23
#0786 PSMA-Targeted Self-Assembled DNA Tetrahedral Nanoprobes for In Vivo Imaging: A Novel Strategy for Non-Invasive Diagnosis and Metastasis Monitoring in Prostate Cancer
04-23
#0740 Autologous Dendritic Cell Vaccination as Add-On Therapy Improves Overall Survival in Stage IV Prostate Cancer: A Retrospective Matched Cohort Study
04-23
#1439 Innovative Approach in Laparoscopic Transvesical Repair of Vesicovaginal Fistulas: A Focus on T Cystostomy
04-23
#1438 Comparison of Laparoscopic Pectopexy and Sacrocolpopexy in Apical Prolapse Management
04-23
#1394 Evaluating the learning curves and clinical outcomes of prostatic urethral lift performed by experienced versus naive urologists
04-23
#1337 Prostate Artery Embolisation safety and efficacy: an Australian multi-centre review
04-23
#1306 1-Monopalmitin inhibits benign prostatic hyperplasia by suppressing endoplasmic reticulum stress and androgen receptor
04-23
#1025 Outcomes of Rezum Water Vapor Therapy for Treatment of Benign Prostatic Hyperplasia: Initial Experience from the Developing World
04-23
#0987 Clinical Outcomes of Contact Laser Vaporization of the Prostate (CVP) : Insights from Pressure Flow Studies
04-23
<
7
8
9
10
11
12
13
14
15
16
>
/ 155